Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26374131)

Published in Eur J Hum Genet on September 16, 2015

Authors

David S Lynch1, Georgios Koutsis2, Arianna Tucci3,4,5, Marios Panas2, Markella Baklou2, Marianthi Breza2, Georgia Karadima2, Henry Houlden3,6

Author Affiliations

1: Department of Molecular Neuroscience, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Queen Square, London, UK The Leonard Wolfson Experimental Neurology Centre, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London UK.
2: Neurogenetics Unit, 1st Department of Neurology, School of Medicine, University of Athens, Athens, Greece.
3: Department of Molecular Neuroscience, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK.
4: Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
5: Department of Pathophysiology & Transplantation, Università degli Studi di Milano, Milano, Italy.
6: Neurogenetics Laboratory, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK.

Articles cited by this

Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol (2013) 2.30

Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy. Neurology (2014) 1.80

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology (2014) 1.73

Next generation sequencing technology: Advances and applications. Biochim Biophys Acta (2014) 1.72

Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat (2009) 1.57

Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol (2014) 1.40

Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain (2012) 1.34

Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet (2008) 1.33

Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet (2011) 1.14

Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. J Neurol Neurosurg Psychiatry (2010) 1.12

Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat (2009) 1.07

A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. Arch Neurol (2006) 1.06

Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia. J Neurol (2013) 1.04

Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet (2011) 1.02

Molecular aspects of hereditary spastic paraplegia. Exp Cell Res (2014) 0.98

Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet (2009) 0.96

Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Pediatr Transplant (2013) 0.86

Exome sequencing released a case of X-linked adrenoleukodystrophy mimicking recessive hereditary spastic paraplegia. Eur J Med Genet (2013) 0.81